Tryton dedicated bifurcation stent in treatment of unprotected distal left main bifurcation disease
| Autor: | James Torey, Saroj Neupane, Nikhil Ambulgekar, Sushruth Edla, Anwar Zaitoun, Antonious Attallah |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Male
medicine.medical_specialty Percutaneous Adverse outcomes medicine.medical_treatment Coronary Artery Disease 030204 cardiovascular system & hematology Coronary Angiography Prosthesis Design 03 medical and health sciences Percutaneous Coronary Intervention 0302 clinical medicine Side branch Humans Medicine cardiovascular diseases 030212 general & internal medicine Ultrasonography Interventional Bifurcation Aged business.industry Percutaneous coronary intervention Stent Drug-Eluting Stents General Medicine equipment and supplies medicine.disease Coronary Vessels Stenosis surgical procedures operative Drug-eluting stent Radiology Cardiology and Cardiovascular Medicine business |
| Zdroj: | Cardiovascular Revascularization Medicine. 19:60-64 |
| ISSN: | 1553-8389 |
| DOI: | 10.1016/j.carrev.2018.05.003 |
| Popis: | Percutaneous coronary interventions involving coronary bifurcation lesions are more complex and associated with adverse outcomes (both angiographic and clinical) compared to non-bifurcation lesions. Tryton, a dedicated bifurcation stent, has been introduced with the aim to simplify treatment of bifurcation lesions. Tryton stent in combination with conventional drug eluting stent is safe and associated with reduced stenosis and bail-out stenting of side branch compared to provisional stenting involving a large side. However, little is known regarding safety and efficacy of Tryton stent in left main (LM) bifurcation lesion. We describe two cases of unprotected LM bifurcation stenting using Tryton stent in combination with drug eluting stent. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect